patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: PSTI files S-3 with SEC.

Not necessarily good, but the shares could also be used for stock splits. And they would be needed if we partner with additional Pharma or BIO companies.

Share
New Message
Please login to post a reply